Page last updated: 2024-11-05

thalidomide and Anophthalmia

thalidomide has been researched along with Anophthalmia in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PAPST, W1
Stanzhevskaia, TI1

Other Studies

2 other studies available for thalidomide and Anophthalmia

ArticleYear
[THALIDOMIDE AND CONGENITAL ABNORMALITIES OF THE EYE].
    Bericht uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft, 1964, Volume: 65

    Topics: Abnormalities, Drug-Induced; Anophthalmos; Child; Eye Diseases; Infant; Learning; Microphthalmos; Op

1964
[Characteristics of the pathogenic effect of thalidomide on the various stages of development in the chick embryo].
    Arkhiv anatomii, gistologii i embriologii, 1966, Volume: 51, Issue:7

    Topics: Abnormalities, Drug-Induced; Animals; Anophthalmos; Brain; Chick Embryo; Eye Abnormalities; Gestatio

1966